| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1085570326 |
| P356 | DOI | 10.1007/S11920-017-0794-6 |
| P698 | PubMed publication ID | 28534294 |
| P50 | author | Benoit H Mulsant | Q90363775 |
| P2093 | author name string | Tarek K Rajji | |
| Aristotle N Voineskos | |||
| Farhana Islam | |||
| P2860 | cites work | New insights into brain BDNF function in normal aging and Alzheimer disease | Q22252335 |
| Prefrontal cortex, caloric restriction and stress during aging: studies on dopamine and acetylcholine release, BDNF and working memory | Q28580179 | ||
| Experience-dependent structural synaptic plasticity in the mammalian brain | Q29619661 | ||
| Plasma BDNF is associated with age-related white matter atrophy but not with cognitive function in older, non-demented adults | Q30468413 | ||
| An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. | Q33572408 | ||
| Neurotrophins and synaptic plasticity | Q33593433 | ||
| Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders | Q33672712 | ||
| Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia | Q33847022 | ||
| Synaptic plasticity: taming the beast | Q33929019 | ||
| Neural plasticity in the ageing brain | Q33992481 | ||
| Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics | Q34019168 | ||
| Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders | Q34048584 | ||
| Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume | Q34110183 | ||
| The neurotrophin hypothesis for synaptic plasticity. | Q34117599 | ||
| Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis | Q34132832 | ||
| Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature | Q34166972 | ||
| Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia: A systematic review | Q34347464 | ||
| Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia | Q34423863 | ||
| BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis | Q34442760 | ||
| Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia | Q34694021 | ||
| Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders | Q34828363 | ||
| Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia | Q35054548 | ||
| Aging and synaptic plasticity: a review | Q35213215 | ||
| Aging and infection reduce expression of specific brain-derived neurotrophic factor mRNAs in hippocampus | Q35613606 | ||
| Schizophrenia as a disorder of neuroplasticity | Q35684683 | ||
| The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? | Q35684687 | ||
| Medical comorbidity in women and men with schizophrenia: a population-based controlled study | Q35696369 | ||
| Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate | Q35902503 | ||
| Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model | Q36219472 | ||
| Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. | Q51963902 | ||
| Memory impairment in schizophrenia: a meta-analysis. | Q52032094 | ||
| Executive function in first-episode schizophrenia. | Q52039614 | ||
| Interaction of BDNF with cytokines in chronic schizophrenia. | Q52148830 | ||
| Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers. | Q54380214 | ||
| Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia | Q61875528 | ||
| Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients | Q73978751 | ||
| The aging brain | Q80015591 | ||
| Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment | Q80383450 | ||
| Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia | Q80745048 | ||
| Working memory impairments in schizophrenia: a meta-analysis | Q36340563 | ||
| Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? | Q36404577 | ||
| Is schizophrenia a syndrome of accelerated aging? | Q37044422 | ||
| BDNF transcripts, proBDNF and proNGF, in the cortex and hippocampus throughout the life span of the rat. | Q37300518 | ||
| A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly | Q37715724 | ||
| Brain-derived neurotrophic factor: findings in schizophrenia | Q37830293 | ||
| Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics | Q38819864 | ||
| The Role of BDNF in Age-Dependent Changes of Excitatory and Inhibitory Synaptic Markers in the Human Prefrontal Cortex | Q39601069 | ||
| Age-related differences in plasma BDNF levels after prolonged bed rest | Q39949615 | ||
| Serum BDNF correlates with connectivity in the (pre)motor hub in the aging human brain--a resting-state fMRI pilot study | Q40039907 | ||
| Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients | Q40361016 | ||
| Excess mortality of schizophrenia. A meta-analysis | Q41728228 | ||
| Accelerated age-related decline in processing resources in schizophrenia: evidence from pupillary responses recorded during the span of apprehension task | Q41729761 | ||
| Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics | Q43135417 | ||
| BDNF and trkB mRNA expression in the hippocampal formation of aging rats | Q43544870 | ||
| Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia | Q44299748 | ||
| Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia | Q44507092 | ||
| Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor | Q44629756 | ||
| Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. | Q44635384 | ||
| Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain | Q44748311 | ||
| The impact of age, weight and gender on BDNF levels in human platelets and plasma | Q45178135 | ||
| Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. | Q45221811 | ||
| BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism | Q45326865 | ||
| BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. | Q46025431 | ||
| Age-related changes in brain-derived neurotrophic factor and tyrosine kinase receptor isoforms in the hippocampus and hypothalamus in male rats | Q46443000 | ||
| Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and neuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus. | Q46588100 | ||
| Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia | Q48186308 | ||
| Neurotrophin-like immunoreactivity in the human hippocampal formation | Q48193657 | ||
| Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder | Q48198300 | ||
| Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains | Q48225092 | ||
| Expression of BDNF and trkB as a function of age and cognitive performance | Q48351465 | ||
| Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3. | Q48353958 | ||
| Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology | Q48397485 | ||
| Age, executive function, and social decision making: a dorsolateral prefrontal theory of cognitive aging. | Q48416284 | ||
| BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex | Q48427415 | ||
| Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes | Q48447557 | ||
| Serum neurotrophins--a study on the time course and influencing factors in a large old age sample | Q48458210 | ||
| BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan | Q48530968 | ||
| Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients | Q48541290 | ||
| Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics | Q48613337 | ||
| Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy | Q48626032 | ||
| Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses | Q48752188 | ||
| Correlation between hippocampal BDNF mRNA expression and memory performance in senescent rats. | Q48753922 | ||
| Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased levels of mRNAs during aging | Q48795076 | ||
| A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia. | Q50668491 | ||
| Cancer risk among parents and siblings of patients with schizophrenia. | Q51907434 | ||
| Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. | Q51929862 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 36 | |
| P577 | publication date | 2017-07-01 | |
| P1433 | published in | Current Psychiatry Reports | Q25245507 |
| P1476 | title | Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia | |
| P478 | volume | 19 |
| Q57812155 | Early Senescence and Leukocyte Telomere Shortening in SCHIZOPHRENIA: A Role for Cytomegalovirus Infection? |
| Q50531661 | Immediate Early Genes Anchor a Biological Pathway of Proteins Required for Memory Formation, Long-Term Depression and Risk for Schizophrenia. |
| Q90565059 | Schizophrenia and Epigenetic Aging Biomarkers: Increased Mortality, Reduced Cancer Risk, and Unique Clozapine Effects |
| Q90745559 | The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications |
| Q92970500 | The Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders |
Search more.